GOLIM4 and neoplasm: Indeed, Mn2+ treatment inhibits the progression of multiple types of 3q-amplified malignancies by degrading GPP130, resulting in a secretory blockade that interrupts pro-survival autocrine loops and attenuates pro-metastatic processes in the tumor microenvironment [23].